UMC | Uppsala Monitoring Centre

WHO Programme members

Currently, 134 countries are full members of the WHO Programme for International Drug Monitoring. Click on a country to see its membership status, date of joining and the name of the national pharmacovigilance centre or authority.

Dark blue: Full member Light blue: Associate member White: Non-member

[{data: [
{"iso-a2":"AF",value:2016,color:"#003763",category:"Full Member", links:[{name:"General Directorate of Pharmaceutical Affairs",link:"http://gdpa.gov.af/en"}]},
{"iso-a2":"AE",value:2013,color:"#003763",category:"Full Member", links:[{name:"United Arab Emirates, Ministry of Health",link:"http://www.cpd-pharma.ae"}]},
{"iso-a2":"AL",value:2011,color:"#009ABE",category:"Associate Member", links:[{name:"National Center of Drugs Control",link:"http://www.akbpm.gov.al"}]},
{"iso-a2":"AD",value:2008,color:"#003763",category:"Full Member", links:[{name:"Service of Pharmacy",link:"http://www.salut.ad/"}]},
{"iso-a2":"AO",value:2013,color:"#003763",category:"Full Member", links:[{name:"Direccao Nacional de Medicamentos e Equipamentos",link:"dnme.co.ao"}]},
{"iso-a2":"AI",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Princess Alexandra Hospital",link:"http://www.paho.org"}]},
{"iso-a2":"AG",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Mount St. John's Medical Centre",link:"http://www.paho.org"}]},
{"iso-a2":"AR",value:1994,color:"#003763",category:"Full Member", links:[{name:"ADMINISTRACION NACIONAL DE MEDICAMENTOS ALIMENTOS Y",link:"http://www.anmat.gov.ar/farmacovigilancia/principal.asp"}]},
{"iso-a2":"AM",value:2001,color:"#003763",category:"Full Member", links:[{name:"Scientific Centre of Drug and Medical Technology",link:"http://pharm.am/index.php/en/drug-safety-profile "}]},
{"iso-a2":"AU",value:1968,color:"#003763",category:"Full Member", links:[{name:"Therapeutic Goods Administration",link:"http://www.tga.gov.au"}]},
{"iso-a2":"AT",value:1991,color:"#003763",category:"Full Member", links:[{name:"Austrian Agency for Health and Food Safety",link:"http://www.basg.gv.at/ www.ages.at"}]},
{"iso-a2":"AZ",value:2018,color:"#003763",category:"Full Member", links:[{name:"Analytical Expertise Center",link:"http://pharma.az/"}]},
{"iso-a2":"BH",value:2002,color:"#009ABE",category:"Associate Member", links:[{name:"Pharmacy and Drug Control",link:"http://www.moh.gov.bh/"}]},
{"iso-a2":"BD",value:2014,color:"#003763",category:"Full Member", links:[{name:"Directorate General of Drug Administration",link:"http://www.dgda.gov.bd/index.php/2013-03-31-04-35-57/adrm-reaction-monitoring"}]},
{"iso-a2":"BB",value:2008,color:"#003763",category:"Full Member", links:[{name:"Barbados Drug Service",link:"http://drugservice.health.gov.bb/"}]},
{"iso-a2":"BY",value:2006,color:"#003763",category:"Full Member", links:[{name:"Center for Examinations and Testing in Health Service",link:"http://rceth.by/ru/Safety"}]},
{"iso-a2":"BE",value:1977,color:"#003763",category:"Full Member", links:[{name:"Federal Agency for Medicines and Health Products",link:"http://www.basg.gv.at/en/basg-austrian-federal-office-for-safety-in-health-care/"}]},
{"iso-a2":"BJ",value:2011,color:"#003763",category:"Full Member", links:[{name:"Direction des Pharmacies et du Médicament",link:"http://www.beninsante.bj"}]},
{"iso-a2":"BT",value:2014,color:"#003763",category:"Full Member", links:[{name:"National Pharmacovigilance Centre",link:"http://dra.gov.bt/"}]},
{"iso-a2":"BO",value:2013,color:"#003763",category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia - Bolivia",link:"http://www.minsalud.gob.bo/"}]},
{"iso-a2":"BA",value:2010,color:"#009ABE",category:"Associate Member", links:[{name:"Agency for Medicines and Medical Devices of Bosnia and Herze",link:"http://www.almbih.gov.ba/"}]},
{"iso-a2":"BW",value:2009,color:"#003763",category:"Full Member", links:[{name:"Drug Regulatory Unit",link:"http://www.moh.gov.bw/"}]},
{"iso-a2":"BR",value:2001,color:"#003763",category:"Full Member", links:[{name:"Agencia Nacional de Vigilanica Sanitaria",link:"http://portal.anvisa.gov.br/farmacovigilancia"},{name:"Universidade de Sao Paulo",link:"Not applicable"}]},
{"iso-a2":"BN",value:2005,color:"#003763",category:"Full Member", links:[{name:"National Adverse Drug Reaction Monitoring Centre",link:"http://www.moh.gov.bn/SitePages/Pharmacy%20Overview.aspx"}]},
{"iso-a2":"BG",value:1975,color:"#003763",category:"Full Member", links:[{name:"Bulgarian Drug Agency",link:"http://www.bda.bg"}]},
{"iso-a2":"BF",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction Generale de la Pharmacie (DGPML)",link:"http://www.dgpml.sante.gov.bf"}]},
{"iso-a2":"BI",value:2010,color:"#009ABE",category:"Associate Member", links:[{name:"Direction de la Pharmacie, du Médicament et des Laboratoires",link:""}]},
{"iso-a2":"CM",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et du Médicament, Cameroon",link:""}]},
{"iso-a2":"CA",value:1968,color:"#003763",category:"Full Member", links:[{name:"Health Canada",link:"http://www.hc-sc.gc.ca"},{name:"Vaccine Preventable Diseases & Vaccine Safety",link:"http://www.phac-aspc.gc.ca"}]},
{"iso-a2":"CV",value:2012,color:"#003763",category:"Full Member", links:[{name:"Agência de Regulacâo e Supervisâo dos Produtos Farmacêuticos",link:"http://www.arfa.cv/index.php/setor-farmaceutico/farmacovigilancia"}]},
{"iso-a2":"CL",value:1996,color:"#003763",category:"Full Member", links:[{name:"Instituto de Salud Publica de Chile",link:"http://www.ispch.cl/anamed_/farmacovigilancia"}]},
{"iso-a2":"CN",value:1998,color:"#003763",category:"Full Member", links:[{name:"China Food and Drug Administration",link:"http://eng.sfda.gov.cn/WS03/CL0755/"}]},
{"iso-a2":"CO",value:2004,color:"#003763",category:"Full Member", links:[{name:"Instituto Nacional de Vigilancia de Medicamentos y Alimentos",link:"https://www.invima.gov.co/index.php?option=com_content&view=article&id=764:farmacovigilancia&catid=191:farmacovigilancia&Itemid=323"}]},
{"iso-a2":"CD",value:2010,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Congo",link:""}]},
{"iso-a2":"CR",value:1991,color:"#003763",category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"http://www.ministeriodesalud.go.cr/index.php/regulacion-de-la-salud/farmacovigilancia"}]},
{"iso-a2":"CI",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et du Médicament, Côte d'Ivoire",link:""}]},
{"iso-a2":"CU",value:1994,color:"#003763",category:"Full Member", links:[{name:"Centro para el Control Estatal de Med., Equip. y Disp. Med.",link:"http://www.cecmed.cu/base-legal/farmacovigilancia"}]},
{"iso-a2":"CY",value:2000,color:"#003763",category:"Full Member", links:[{name:"Pharmaceutical Services",link:"http://www.moh.gov.cy/moh/phs/phs.nsf/dmlindex_en/dmlindex_en?opendocument"}]},
{"iso-a2":"CZ",value:1992,color:"#003763",category:"Full Member", links:[{name:"State Institute for Drug Control, Czech Republic",link:"http://www.sukl.eu/index.php?lang=2"}]},
{"iso-a2":"CH",value:1991,color:"#003763",category:"Full Member", links:[{name:"Swissmedic",link:"https://www.swissmedic.ch/marktueberwachung/00135/00160/index.html?lang=en"}]},
{"iso-a2":"DE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Federal Institute for Drugs and Medical Devices",link:"http://www.bfarm.de/cln_012/nn_424276/EN"},{name:"Paul Ehrlich Institut",link:"http://www.pei.de/EN/home/node.html"}]},
{"iso-a2":"DZ",value:2006,color:"#009ABE",category:"Associate Member", links:[{name:"Nouvel Institut Pasteur d'Algérie",link:"http://www.cnpm.org.dz"}]},
{"iso-a2":"DK",value:1971,color:"#003763",category:"Full Member", links:[{name:"Danish Medicines Agency",link:"http://laegemiddelstyrelsen.dk/en"}]},
{"iso-a2":"DM",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Grand Health Center",link:"http://www.paho.org"}]},
{"iso-a2":"EC",value:2017,color:"#003763",category:"Full Member", links:[{name:"Agencia Nacional de Reg. Contr. y Vigilanc. Sanit.",link:"http://www.controlsanitario.gob.ec"}]},
{"iso-a2":"ES",value:1984,color:"#003763",category:"Full Member", links:[{name:"Spanish Agency for Medicines and Healthcare Products",link:"https://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/home.htm"}]},
{"iso-a2":"ET",value:2008,color:"#003763",category:"Full Member", links:[{name:"ET Food, Medicine & Healthcare Admin and Control Authority",link:"http://www.fmhaca.gov.et/pharmacovigilance.html"}]},
{"iso-a2":"ER",value:2012,color:"#003763",category:"Full Member", links:[{name:"Eritrean National Pharmacovigilance Centre",link:"http://pveritrea.com/"}]},
{"iso-a2":"EE",value:1998,color:"#003763",category:"Full Member", links:[{name:"State Agency of Medicines",link:"http://www.ravimiamet.ee/en"}]},
{"iso-a2":"EG",value:2001,color:"#003763",category:"Full Member", links:[{name:"Egyptian Pharmaceutical Vigilance Center",link:"http://www.epvc.gov.eg/"}]},
{"iso-a2":"FJ",value:1999,color:"#003763",category:"Full Member", links:[{name:"Fiji Pharmaceutical & Biomedical Services Centre",link:"http://www.health.gov.fj"}]},
{"iso-a2":"FI",value:1974,color:"#003763",category:"Full Member", links:[{name:"Finnish Medicines Agency",link:"http://www.fimea.fi/web/en/pharmaceutical_safety_and_information"}]},
{"iso-a2":"FR",value:1986,color:"#003763",category:"Full Member", links:[{name:"Agence nationale de sécurité du méd. et des prod. de santé",link:"http://ansm.sante.fr"}]},
{"iso-a2":"GM",value:2011,color:"#009ABE",category:"Associate Member", links:[{name:"Medicines Control Agency",link:""}]},
{"iso-a2":"GE",value:2018,color:"#003763",category:"Full Member", links:[{name:"National Center of Pharmacovigilance",link:"http://moh.gov.ge"}]},
{"iso-a2":"GH",value:2001,color:"#003763",category:"Full Member", links:[{name:"Food and Drugs Authority",link:"http://www.fdaghana.gov.gh"}]},
{"iso-a2":"GR",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Organization for Medicines",link:"http://www.eof.gr/web/guest/home"}]},
{"iso-a2":"GD",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Central Medical Stores, Grenada",link:"http://www.paho.org"}]},
{"iso-a2":"GT",value:2002,color:"#003763",category:"Full Member", links:[{name:"Ministerio de Salud Publica y Asistencia Social",link:"http://www.mspas.gob.gt/index.php/en/servicios/farmacovigilancia.html"}]},
{"iso-a2":"GN",value:2013,color:"#003763",category:"Full Member", links:[{name:"Direction Nationale de la Pharmacie et des Laboratoires",link:""}]},
{"iso-a2":"GY",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Public Health",link:"http://www.health.gov.gy"}]},
{"iso-a2":"GW",value:2009,color:"#009ABE",category:"Associate Member", links:[{name:"Guinée-Bissau Ministério da Saúde",link:""}]},
{"iso-a2":"GB",value:1968,color:"#003763",category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]},
{"iso-a2":"HR",value:1992,color:"#003763",category:"Full Member", links:[{name:"Croatian Agency for Medicinal Products and Devices",link:"http://www.halmed.hr/en/"}]},
{"iso-a2":"HU",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Institute of Pharmacy and Nutrion",link:"https://www.ogyei.gov.hu/pharmacovigilance/"}]},
{"iso-a2":"HT",value:2016,color:"#009ABE",category:"Associate Member", links:[{name:"Ministère Santé Publique et de la Population",link:"http://mspp.gouv.ht/newsite/"}]},
{"iso-a2":"IS",value:1990,color:"#003763",category:"Full Member", links:[{name:"Icelandic Medicines Agency",link:"http://www.ima.is/Pharmacovigilance/"}]},
{"iso-a2":"IN",value:1998,color:"#003763",category:"Full Member", links:[{name:"Indian Pharmacopoeia Commission",link:"http://www.ipc.gov.in"}]},
{"iso-a2":"ID",value:1975,color:"#003763",category:"Full Member", links:[{name:"Indonesia National Agency of Drug and Food Control",link:"http://www.pom.go.id/new/index.php/home/en"}]},
{"iso-a2":"IR",value:1998,color:"#003763",category:"Full Member", links:[{name:"Iranian Adverse Drug Reaction Monitoring Centre",link:"http://www.mohme.gov.ir"}]},
{"iso-a2":"IQ",value:2010,color:"#003763",category:"Full Member", links:[{name:"Iraqi Pharmacovigilance Center",link:"http://www.mohiraq.org"}]},
{"iso-a2":"IE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Health Products Regulatory Authority",link:"http://www.hpra.ie/homepage/medicines"}]},
{"iso-a2":"IL",value:1973,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Information and Risk Management",link:"http://www.health.gov.il/English/MinistryUnits/HealthDivision/MedicalTechnologies/Drugs/risk/Pages/default.aspx"}]},
{"iso-a2":"IT",value:1975,color:"#003763",category:"Full Member", links:[{name:"Agenzia Italiana del Farmaco",link:"http://www.agenziafarmaco.gov.it/en/content/post-marketing-surveillance"}]},
{"iso-a2":"JM",value:2012,color:"#003763",category:"Full Member", links:[{name:"Pharmwatch Jamaica",link:"http://www.moh.gov.jm"}]},
{"iso-a2":"JP",value:1972,color:"#003763",category:"Full Member", links:[{name:"Pharmaceuticals and Medical Devices Agency",link:"http://www.pmda.go.jp/english/index.html"}]},
{"iso-a2":"JO",value:2002,color:"#003763",category:"Full Member", links:[{name:"Jordan Food and Drug Administration",link:"http://www.jfda.jo"}]},
{"iso-a2":"KH",value:2012,color:"#003763",category:"Full Member", links:[{name:"Cambodian Pharmacovigilance Center",link:"http://www.ddfcambodia.com"}]},
{"iso-a2":"KZ",value:2008,color:"#003763",category:"Full Member", links:[{name:"National Center for drug expertise, items for medical use an",link:"http://dari.kz/category/monitoring "}]},
{"iso-a2":"KE",value:2010,color:"#003763",category:"Full Member", links:[{name:"Pharmacy and Poisons Board",link:"http://www.pharmacyboardkenya.org"}]},
{"iso-a2":"KR",value:1992,color:"#003763",category:"Full Member", links:[{name:"Ministry of Food and Drug Safety",link:" http://www.mfds.go.kr/eng/index.do"}]},
{"iso-a2":"KG",value:2003,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Provision & Medical Equipment",link:"http://pharm.kg/ru/farmakonadzor/ "}]},
{"iso-a2":"KN",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Health, St. Kitts and Nevis",link:"http://www.paho.org"}]},
{"iso-a2":"KW",value:2018,color:"#009ABE",category:"Associate Member", links:[]},
{"iso-a2":"LA",value:2015,color:"#003763",category:"Full Member", links:[{name:"Food and Drug Department, Ministry of Health",link:"http://www.fdd.gov.la"}]},
{"iso-a2":"LB",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Public Health",link:"http:/www.phcvg.ul.edu.lb"}]},
{"iso-a2":"LV",value:2002,color:"#003763",category:"Full Member", links:[{name:"State Agency of Medicines of Latvia",link:"https://www.zva.gov.lv//?id=420&sa=420&top=386"}]},
{"iso-a2":"LR",value:2013,color:"#003763",category:"Full Member", links:[{name:"Liberia Medicines and Health Products Regulatory Authority",link:"http://www.lmhralib.org/departments/pharmacovigilance/"}]},
{"iso-a2":"LT",value:2005,color:"#003763",category:"Full Member", links:[{name:"State Medicines Control Agency",link:"http://www.vvkt.lt/Pharmacovigilance"}]},
{"iso-a2":"LC",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"OECS - Pharmaceutical Procurement Service",link:"http://www.oecs.org/"},{name:"Ministry of Health, St Lucia",link:"http://www.paho.org"}]},
{"iso-a2":"LK",value:2000,color:"#003763",category:"Full Member", links:[{name:"National Medicines Regulatory Authority",link:"http://www.cdda.gov.lk"}]},
{"iso-a2":"LY",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Health",link:"http://www.health.gov.ly/"}]},
{"iso-a2":"MK",value:2000,color:"#003763",category:"Full Member", links:[{name:"Macedonian Agency for medicines and medical devices",link:"http://www.moh.gov.mk "}]},
{"iso-a2":"MG",value:2009,color:"#003763",category:"Full Member", links:[{name:"Agence du Médicament de Madagascar",link:"http://www.sante.gov.mg"}]},
{"iso-a2":"MW",value:2016,color:"#009ABE",category:"Associate Member", links:[{name:"Pharmacy, Medicines and Poisons Board",link:"http://www.health.gov.mw "}]},
{"iso-a2":"MY",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Pharmaceutical Control Bureau",link:"http://npra.moh.gov.my"}]},
{"iso-a2":"MV",value:2016,color:"#003763",category:"Full Member", links:[{name:"Maldives Food and Drug Authority",link:"http://www.mfda.gov.mv/English/index.php"}]},
{"iso-a2":"ML",value:2011,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Mali",link:""}]},
{"iso-a2":"MM",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Department of Food and Drug Administration, Ministry of Health and Sports",link:"http://www.fdamyanmar.gov.mm/"}]},
{"iso-a2":"MT",value:2004,color:"#003763",category:"Full Member", links:[{name:"Malta Medicines Authority",link:"http://www.medicinesauthority.gov.mt"}]},
{"iso-a2":"MU",value:2014,color:"#003763",category:"Full Member", links:[{name:"National PV centre of Mauritius",link:""}]},
{"iso-a2":"MX",value:1999,color:"#003763",category:"Full Member", links:[{name:"Federal Commission for the Protection against Sanitary Risk",link:"http://www.cofepris.gob.mx/AZ/Paginas/Farmacovigilancia/Farmacovigilancia.aspx"}]},
{"iso-a2":"MD",value:2003,color:"#003763",category:"Full Member", links:[{name:"Medicines Agency",link:"http://amed.md/en/content/pharmacovigilance "}]},
{"iso-a2":"MN",value:2005,color:"#009ABE",category:"Associate Member", links:[{name:"Drug Regulation Division, Center for Health Development",link:""}]},
{"iso-a2":"ME",value:2009,color:"#003763",category:"Full Member", links:[{name:"Agency for Medicines and Medical Devices",link:"http://www.mzd.gov.me"}]},
{"iso-a2":"MS",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Glendon Hospital Pharmacy",link:"http://www.paho.org"}]},
{"iso-a2":"MA",value:1992,color:"#003763",category:"Full Member", links:[{name:"Centre Anti Poison et de Pharmacovigilance",link:"http://www.capm.ma"}]},
{"iso-a2":"MZ",value:2005,color:"#003763",category:"Full Member", links:[{name:"Pharmaceutical Department",link:"http://www.misau.gov.mz/index.php"}]},
{"iso-a2":"NA",value:2008,color:"#003763",category:"Full Member", links:[{name:"Namibia Medicines Regulatory Council",link:"http://www.nmrc.com.na/tipc"}]},
{"iso-a2":"NP",value:2006,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Administration",link:"http://www.dda.gov.np"}]},
{"iso-a2":"NL",value:1968,color:"#003763",category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]},
{"iso-a2":"NZ",value:1968,color:"#003763",category:"Full Member", links:[{name:"New Zealand Pharmacovigilance Centre",link:"http://www.otago.ac.nz/carm"}]},
{"iso-a2":"NE",value:2012,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie, des Laboratoires et de la Médecin",link:""}]},
{"iso-a2":"NG",value:2004,color:"#003763",category:"Full Member", links:[{name:"National Agency for Food and Drug Administration and Control",link:"http://www.nafdac.gov.ng/index.php/about-nafdac/faqs/pharmacovigilance"}]},
{"iso-a2":"NO",value:1971,color:"#003763",category:"Full Member", links:[{name:"Norwegian Medicines Agency",link:"https://legemiddelverket.no/English"}]},
{"iso-a2":"OM",value:1995,color:"#003763",category:"Full Member", links:[{name:"Directorate General Pharmaceutical Affairs and Drug Control",link:"https://www.moh.gov.om/en_US/web/dgpadc"}]},
{"iso-a2":"PK",value:1994,color:"#009ABE",category:"Associate Member", links:[{name:"Drug Regulatory Authority of Pakistan",link:"http://www.dra.gov.pk"}]},
{"iso-a2":"PA",value:2005,color:"#003763",category:"Full Member", links:[{name:"Dirección Nacional de Farmacia y Drogas del Minist. de Salud",link:"http://www.minsa.gob.pa/informacion-salud/centro-nacional-de-farmacovigilancia"}]},
{"iso-a2":"PG",value:2018,color:"#003763",category:"Full Member", links:[{name:"Papua New Guinea Drug Information and Pharmacovigilance Unit",link:"http://www.health.gov.pg"}]},
{"iso-a2":"PE",value:2002,color:"#003763",category:"Full Member", links:[{name:"Direccion General de Medicamentos, Insumos y Drogas",link:"http://www.digemid.minsa.gob.pe/main.asp?Seccion=572"}]},
{"iso-a2":"PH",value:1995,color:"#003763",category:"Full Member", links:[{name:"Food and Drug Administration, Philippines",link:"http://www.fda.gov.ph"}]},
{"iso-a2":"PK",value:2018,color:"#003763",category:"Full Member", links:[{name:"Drug Regulatory Authority of Pakistan",link:"http://www.dra.gov.pk/"}]},
{"iso-a2":"PL",value:1972,color:"#003763",category:"Full Member", links:[{name:"Office for Registration of Medicinal Products, URPL",link:"http://www.urpl.gov.pl/en"}]},
{"iso-a2":"PT",value:1993,color:"#003763",category:"Full Member", links:[{name:"INFARMED",link:"http://www.infarmed.pt/web/infarmed/entidades/medicamentos-uso-humano/farmacovigilancia"}]},
{"iso-a2":"PY",value:2018,color:"#003763",category:"Full Member", links:[{name:"Dirección Nacional de Vigilancia Sanitaria",link:"https://www.mspbs.gov.py/dnvs"}]},
{"iso-a2":"QA",value:2013,color:"#009ABE",category:"Associate Member", links:[{name:"Supreme Council of Health",link:"https://www.moph.gov.qa/home-en"}]},
{"iso-a2":"RO",value:1976,color:"#003763",category:"Full Member", links:[{name:"National Agency for Medicines and Medical Devices",link:"http://www.anm.ro/anmdm/en/index.html"}]},
{"iso-a2":"RU",value:1998,color:"#003763",category:"Full Member", links:[{name:"Federal Service on Surveillance in Healthcare and Soc.Dev",link:"http://www.roszdravnadzor.ru/drugs/monitpringlp "}]},
{"iso-a2":"RW",value:2013,color:"#003763",category:"Full Member", links:[{name:"Pharmacy Task Force, Ministry of Health",link:"http://www.moh.gov.rw"}]},
{"iso-a2":"RS",value:2000,color:"#003763",category:"Full Member", links:[{name:"Medicines and Medical Devices Agency of Serbia",link:"http://www.alims.gov.rs"}]},
{"iso-a2":"SV",value:2017,color:"#003763",category:"Full Member", links:[{name:"Ministerio de Salud de El Salvador",link:"http://www.salud.gob.sv"}]},
{"iso-a2":"SA",value:2009,color:"#003763",category:"Full Member", links:[{name:"Saudi Food and Drug Authority",link:"http://www.sfda.gov.sa/EN/DRUG/ABOUT/SECTOR_DEPARTMENTS/NATIONAL_PHARMACOVIGILANCE_CENTER/Pages/default.aspx"}]},
{"iso-a2":"SS",value:2018,color:"#009ABE",category:"Associate Member",links:[{name:"",link:""}]},
{"iso-a2":"SN",value:2009,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et des Laboratoires",link:"http://www.sante.gouv.sn"}]},
{"iso-a2":"SL",value:2008,color:"#003763",category:"Full Member", links:[{name:"Pharmacy Board of Sierra Leone",link:"http://www.pharmacyboard.gov.sl"}]},
{"iso-a2":"SG",value:1993,color:"#003763",category:"Full Member", links:[{name:"Health Sciences Authority",link:"http://www.hsa.gov.sg"}]},
{"iso-a2":"SK",value:1993,color:"#003763",category:"Full Member", links:[{name:"State Institute for Drug Control, Slovakia",link:"http://www.sukl.sk/en/drug-safety/scope-of-activities?page_id=4020"}]},
{"iso-a2":"SI",value:2010,color:"#003763",category:"Full Member", links:[{name:"Agency for medicinal products and medical devices",link:"http://www.jazmp.si/en/"}]},
{"iso-a2":"SD",value:2008,color:"#003763",category:"Full Member", links:[{name:"National Medicines and Poisons Board",link:"http://www.nmpb.gov.sd/"}]},
{"iso-a2":"SR",value:2007,color:"#003763",category:"Full Member", links:[{name:"Office of Pharmacy Policy",link:""}]},
{"iso-a2":"SZ",value:2015,color:"#003763",category:"Full Member", links:[{name:"Swaziland Pharmacovigilance Centre - Central Medical Stores",link:"http://www.gov.sz/index.php?option=com_content&view=article&id=267&Itemid=403"}]},
{"iso-a2":"SE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Medical Products Agency",link:"https://lakemedelsverket.se/english/"}]},
{"iso-a2":"SY",value:2018,color:"#003763",category:"Full Member", links:[{name:"Syrian Ministry of Health",link:"http://www.moh.gov.sy"}]},
{"iso-a2":"TD",value:2018,color:"#003763",category:"Full Member", links:[{name:"Bureau de Pharmacovigilance",link:"http://www.sante-tchad.org"}]},
{"iso-a2":"TZ",value:1993,color:"#003763",category:"Full Member", links:[{name:"Tanzania Food and Drugs Authority",link:"http://www.tfda.or.tz"}]},
{"iso-a2":"TH",value:1984,color:"#003763",category:"Full Member", links:[{name:"Thai Food and Drug Administration",link:"http://thaihpvc.fda.moph.go.th/thaihvc/index.jsf"}]},
{"iso-a2":"TG",value:2007,color:"#003763",category:"Full Member", links:[{name:"Direction des Pharmacies, Togo",link:"http://www.everyoneweb.fr/pharmacovigilance"}]},
{"iso-a2":"TN",value:1993,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Tunisia",link:""}]},
{"iso-a2":"TR",value:1987,color:"#003763",category:"Full Member", links:[{name:"Turkish Pharmacovigilance Center",link:"http://www.titck.gov.tr"}]},
{"iso-a2":"TJ",value:2015,color:"#009ABE",category:"Associate Member", links:[{name:"Office of National Supervision for Pharmaceutical Activities",link:"http://www.pharmnadzor.tj/index.html"}]},
{"iso-a2":"UG",value:2007,color:"#003763",category:"Full Member", links:[{name:"National Drug Authority",link:"http://www.nda.or.ug"}]},
{"iso-a2":"UA",value:2002,color:"#003763",category:"Full Member", links:[{name:"State Expert Center",link:"http://www.dec.gov.ua/index.php/ua/farmakonaglyad "}]},
{"iso-a2":"US",value:1968,color:"#003763",category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:"US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]},
{"iso-a2":"UY",value:2001,color:"#003763",category:"Full Member", links:[{name:"Department of Pharmaceuticals",link:"http://www.msp.gub.uy"}]},
{"iso-a2":"UZ",value:2006,color:"#003763",category:"Full Member", links:[{name:"Pharmacological Committee of HDDMEC",link:"http://pharm-reg.uz/info/structure/farmakolog/ "}]},
{"iso-a2":"VC",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"SVG Pharmacovigilance & Drug Information Centre",link:"http://www.paho.org"}]},
{"iso-a2":"VE",value:1995,color:"#003763",category:"Full Member", links:[{name:"Instituto Nacional de Higiene, Rafael Rangel",link:"http://www.inhrr.gob.ve/sistema_nacional_farmacovigilancia_ce.php"}]},
{"iso-a2":"VN",value:1999,color:"#003763",category:"Full Member", links:[{name:"National Centre of Drug Information & Adverse Drug Reactions",link:"http://canhgiacduoc.org.vn/en.aspx"}]},
{"iso-a2":"VI",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Drugs & Pharmaceutical Services",link:"http://www.paho.org"}]},
{"iso-a2":"YE",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Supreme Board of Drugs and Medical Appliances",link:"http://www.sbd-ye.org/"}]},
{"iso-a2":"ZA",value:1992,color:"#003763",category:"Full Member", links:[{name:"Medicines Regulatory Authority",link:"http://www.mccza.com/"}]},
{"iso-a2":"Zanzi",value:2007,color:"#009ABE",category:"Associate Member", links:[{name:"Zanzibar Food and Drugs Board",link:"http://www.zfdb.go.tz"}]},
{"iso-a2":"ZM",value:2010,color:"#003763",category:"Full Member", links:[{name:"Zambia Medicines Regulatory Authority",link:"http://www.zamra.co.zm"}]},
{"iso-a2":"ZW",value:1998,color:"#003763",category:"Full Member", links:[{name:"Medicines Control Authority of Zimbabwe",link:"http://www.mcaz.co.zw"}]}],joinBy: 'iso-a2',name: 'Member status',mapData: Highcharts.maps['custom/world-palestine'],states: { hover: { color: '#a02741' }}}]

*This map is an approximation of actual country borders.

Welcome to Uppsala Monitoring Centre!

A global culture of patient safety

Working for a better world

Safer use of medicines

WHO Programme members

Introduction

WHODrug

About UMC